Unit Outline
CSA725
Advanced Pharmacotherapeutics in Endocrinology, Rheumatology and Oncology Care
Semester 1, 2024
Mohammed Salahudeen
School of Pharmacy and Pharmacology
College of Health and Medicine
CRICOS Provider Code: 00586B

Unit Coordinator
Mohammed Salahudeen
Email: Mohammed.Salahudeen@utas.edu.au
 

What is the Unit About?
Unit Description
CSA725 is a self-directed, fully on-line unit, that explores a variety of disease states and their management, using a series of patient cases linked to assignment-based questions, to enable the student to enhance their knowledge in the area of clinical pharmacy and pharmaceutical care. This unit covers the medication management and clinical pharmacy issues in endocrinology, rheumatology and oncology supportive care.
Intended Learning Outcomes
As per the Assessment and Results Policy 1.3, your results will reflect your achievement against specified learning outcomes.
On completion of this unit, you will be able to:
1.
Identify and evaluate problems associated with endocrine, rheumatoid and oncological medications using an evidence-based approach.
2.
Critically evaluate endocrine, rheumatoid and oncological medication therapy using an evidence-based approach and accepted best clinical practice to devise and justify appropriate courses of action for therapeutic management.
3.
Employ evidence-based and contemporary clinical skills to conduct a clinical audit and demonstrate how this may influence pharmacy practice in the management of endocrine, rheumatoid or oncological diseases.
4.
Demonstrate effective written and oral presentation skills to explain contemporary issues associated with endocrine, rheumatoid and oncological medication therapy.
Requisites
REQUISITE TYPE
REQUISITES
Concurrent Pre-requisite
CSA721
Alterations as a result of student feedback
No alterations have been made as a result of student feedback. 
 
 

Teaching arrangements
ATTENDANCE MODE
TEACHING TYPE
LEARNING ACTIVITY
CONTACT HOURS
FREQUENCY
Online
Independent Learning
Online via MyLO and Online tutorial and meeting rooms.
10
Weekly
Attendance / engagement expectations
If your unit is offered On campus, it is expected that you will attend all on-campus and onsite learning activities. This is to support your own learning and the development of a learning community within the unit. If you are unable to attend regularly, please discuss the situation with your course coordinator and/or our UConnect support team.

If your unit is offered Online, it is expected you will engage in all those activities as indicated in the Unit Outline, including any self-directed learning.

If you miss a learning activity for a legitimate reason (e.g., illness, carer responsibilities) teaching staff will attempt to provide alternative activities (e.g., make up readings) where it is possible.
 
While there is no mandatory attendance for this course, active participation in Zoom sessions and tutorials is highly recommended to enhance your learning experience. These sessions provide valuable opportunities for interaction, discussion, and clarification of concepts. In the event that you are unable to attend live sessions, recordings will be made available for your convenience. 
 
 

How will I be Assessed?
 
For more detailed assessment information please see MyLO.
Assessment schedule
ASSESSMENT TASK #
ASSESSMENT TASK NAME
DATE DUE
WEIGHT
LINKS TO INTENDED LEARNING OUTCOMES
Assessment Task 1:
Quiz
Week 3
5 %
LO1
Assessment Task 2:
Assignment 1
Week 4
15 %
LO1, LO2
Assessment Task 3:
Assignment 2
Week 6
25 %
LO1, LO2, LO3
Assessment Task 4:
Assignment 3
Week 10
35 %
LO2, LO3, LO4
Assessment Task 5:
Assignment 4
Week 13
20 %
LO3, LO4
 
Assessment details
    
Assessment Task 1: Quiz
Task Description:
A quiz with multiple choice and short answer questions specific to endocrinology, rheumatology or oncology. You will be answering these questions using current guidelines and evidence from the literature.

Task Length:
A mix of multiple and/or short answer questions.
Due Date:
Week 3
Weight:
5 %
 
CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
1
Details on assessment criteria are available in MyLO
LO1
 
Assessment Task 2: Assignment 1
Task Description:
Assignment 1 will present you with a practice-based current concept. You will then give a summary of your understanding of the topic by means of relevant literature

Task Length:
750 words
Due Date:
Week 4
Weight:
15 %
 
 

CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
1
Details on assessment criteria are available in MyLO
LO1, LO2
 
Assessment Task 3: Assignment 2
Task Description:
Assignment 2 involves one short case with specific questions. You will be answering these questions using current literature.

Task Length:
1500 words
Due Date:
Week 6
Weight:
25 %
 
CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
1
Details on assessment criteria are available in MyLO
LO1, LO2, LO3
 
Assessment Task 4: Assignment 3
Task Description:
Assignment 3 will involve answering clinical questions related to a detailed clinical case. You will also provide a feedback/critique of the given document

Task Length:
3000 words
Due Date:
Week 10
Weight:
35 %
 
CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
1
Details on assessment criteria are available in MyLO
LO2, LO3, LO4
 
Assessment Task 5: Assignment 4
Task Description:
Assignment 4 involves preparing and delivering an engaging scientific poster presentation on a given clinical topic. You will select one of several clinical topics related to pharmacy practice of endocrine, rheumatology and oncology disorders. You will present a case study or quality improvement project drawn from your practice. You must support your presentation with contemporary literary evidence.
Please refer to MyLO for details.

Task Length:
15 minutes
Due Date:
Week 13
Weight:
20 %
 
CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
 

1
Details on assessment criteria are available in MyLO
LO3, LO4
 
 
 

How your final result is determined
To pass this unit, you need to demonstrate your attainment of each of the Intended Learning Outcomes, achieve a final unit grade of 50% or greater, and pass any hurdle tasks.
 
Submission of assignments
Where practicable, assignments should be submitted to an assignment submission folder in MYLO. You must submit assignments by the due date or receive a penalty (unless an extension of time has been approved by the Unit Coordinator). Students submitting any assignment in hard copy, or because of a practicum finalisation, must attach a student cover sheet and signed declaration for the submission to be accepted for marking.
 
Requests for extensions
If you are unable to submit an assessment task by the due date, you should apply for an extension.
 
A request for an extension should first be discussed with your Unit Coordinator or teaching support team where possible. A request for an extension must be submitted by the assessment due date, except where you can provide evidence it was not possible to do so. Typically, an application for an extension will be supported by documentary evidence: however, where it is not possible for you to provide evidence please contact your Unit Coordinator.
 
The Unit Coordinator must notify you of the outcome of an extension request within 3 working days of receiving the request.
Late penalties
Assignments submitted after the deadline will receive a late penalty of 5% of the original available mark for each calendar day (or part day) that the assignment is late. Late submissions will not be accepted more than 10 calendar days after the due date, or after assignments have been returned to other students on a scheduled date, whichever occurs first. Further information on Late Penalties can be found on the Assessments and Results Procedure.
 
Review of results and appeals
You are entitled to ask for a review of the marking and grading of your assessment task if there is an irregularity in the marking standards or an error in the process for determining the outcome of an assessment. Details on how to request a review of a mark for an assignment are outlined in the Review and Appeal of Academic Decisions Procedure.
 
 
 

Required Resources
Required reading materials
 
 
Recommended reading materials
It is highly recommended that you study topics relevant to your unit from standard clinical pharmacy texts such as Pharmacotherapy by Joseph T DiPiro 11th Edition OR Applied Therapeutics by Koda-Kimble 11th Edition. There is a wide range of textbooks available online that can be accessed through the UTAS library. 
We assume that Pharmacists undertaking the course will have a general knowledge of most of the therapeutic areas covered, as well as have the necessary skills to interpret laboratory and patient data. Some students may need to refresh and revise this knowledge, due to the many different backgrounds and training that our students have. 
 
Other required resources